Study shows how MS patients treated with Rituximab react to COVID-19 vaccination
MS patients treated with Rituximab have better responses to the COVID-19 vaccine if they have higher B cell counts.
Uppsala Lan Anna Wiberg Andreas Tolf Emily Henderson Uppsala University Researchers At Uppsala University
Source: news-medical.net